Immunogenicity and Duration of Immunity in Immunosuppressed Children Vaccinated With Quadrivalent HPV Vaccine
Phase of Trial: Phase III
Latest Information Update: 08 May 2017
At a glance
- Drugs Human papillomavirus vaccine recombinant quadrivalent Merck (Primary)
- Indications Cervical cancer; Human polyomavirus infections
- Focus Pharmacodynamics; Registrational
- 01 May 2017 Status changed from active, no longer recruiting to completed.
- 25 Nov 2016 Planned End Date changed from 1 Aug 2016 to 1 Dec 2016.
- 09 Jul 2016 Results published in the Vaccine